| Nicole Schiavone is a Principal Scientist at Pfizer within Analytical Research & Development. She earned her Ph.D. from the University of Notre Dame where she developed a capillary electrophoresis-mass spectroscopy (CE-MS) workflow for metabolomics. She then completed a postdoctoral fellowship at Merck focused on applying hydrogen-deuterium exchange (HDX)-MS and circular dichroism to study global conformational changes of peptides in solution. At Pfizer, Nicole currently leads mRNA vaccine analytical strategy and method development. |
